查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2010004

生物材料市场：按类型、分类、最终用户和应用划分－2026-2032年全球市场预测

Biomaterials Market by Type, Classification, End User, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，生物材料市场价值将达到 560.7 亿美元，到 2026 年将成长至 630.2 亿美元，到 2032 年将达到 1,313 亿美元，复合年增长率为 12.92%。

主要市场统计数据
基准年 2025 560.7亿美元
预计年份：2026年 630.2亿美元
预测年份 2032 1313亿美元
复合年增长率 (%) 12.92%

全面概述了塑造生物材料产业的当前趋势、核心技术基础和前沿研究。

生物材料已成为现代医学的关键基石，推动了组织工程、药物传输和医疗设备创新等领域的突破性进展。近年来，聚合物化学、陶瓷复合材料和金属合金等领域的进步融合，拓展了植入和再生医学的功能。本文概述了生物材料在改善患者预后和促进材料科学家、临床医生和製造专家之间的跨学科合作方面所发挥的关键作用。

新一代材料、先进製造技术和协作创新模式推动了生物材料开发的革命性变革。

在新一代材料和创新製造技术的推动下，生物材料领域正经历快速变化。积层製造技术的进步使得快速植入复杂植入物原型成为可能，同时确保了高度可重复的品质标准。同时，奈米技术的突破也使得表面改质变得更加容易，从而增强细胞黏附并促进癒合反应。

评估2025年生效的美国新关税对生医材料市场供应链、成本结构和竞争力的累积影响。

美国2025年实施的新关税预计将重塑生医材料市场供应链，影响关键原料的成本和供应。从主要製造地进口的陶瓷和特殊金属合金可能面临更高的关税负担，导致下游医疗设备製造商的生产成本上升。为因应此问题，各公司正在探索替代筹资策略，包括近岸外包和双重采购，以降低贸易波动带来的风险。

对生物材料市场进行深入分析，从材料类型、分类、最终用户和各种应用领域入手，推动策略重点。

生物材料市场的細項分析揭示了材料类型、功能分类、使用者群体和应用领域等方面的明确机会。就材料类型而言，氧化铝、生物玻璃、羟磷石灰和氧化锆等陶瓷材料在硬组织植入中仍然至关重要，而金属基材仍然是承重关节重建的基础。天然聚合物以其生物相容性优势补充了这些分类，而从聚己内酯到聚乳酸-羟基乙酸共聚物和聚乙烯醇等合成聚合物则为支架设计和药物递送基质提供了多样化的选择。

策略区域洞察：揭示美洲、欧洲、中东、非洲和亚太地区生医材料生态系统的成长动态和市场驱动因素

区域趋势对于理解生物材料产业的发展演变至关重要。在美洲，完善的基础设施和大量的研发投入建构了一个有利于产品快速开发和临床试验的生态系统。北美监管体係以系统化的核准流程为特征，为创新者提供了清晰的蓝图；而拉丁美洲市场则在医疗保健覆盖范围扩大和改革倡议的推动下，创造了新的机会。

企业洞察，重点在于竞争考察、创新管道以及领先生医材料供应商之间的伙伴关係。

生物材料领域的主要企业正透过整合创新管线和策略合作实现差异化竞争。以全球布局着称的大型医疗设备製造商正利用其专有的生物活性涂层和先进的聚合物配方技术拓展产品线。同时，特种化学品製造商正凭藉其在高纯度材料方面的专业知识，满足严格的生物相容性要求，并扩大其在临床市场的份额。

为产业领导者提供实用建议，帮助他们利用新兴趋势、优化供应链，并透过策略倡议巩固市场地位。

产业领导者应优先投资生物活性和再生医学材料，以满足尚未满足的临床需求，并利用与研究机构的合作来加速转化研究。透过在产品开发中采用模组化方法，企业可以在将各个组件整合到综合治疗平台之前进行单独检验，从而缩短产品上市时间并降低技术风险。

采用稳健的调查方法，强调全面的资料收集、多方面的资讯匹配以及严格的定性和定量分析，以确保可靠性。

本分析采用严谨的调查方法，结合了全面的二手资料研究、针对性的一手访谈和资料检验。公开的科学文献、监管文件和专利资料库为材料创新和市场趋势提供了重要的见解。除上述资讯来源外，本分析还补充了对材料科学家、生物医学工程师以及供应链和临床机构高级决策者的访谈。

这总结了关键发现，突显了市场机会，并提供了明确的见解，从而强化了生物材料相关人员的策略重点。

研究结果凸显了技术创新、监管演变和全球贸易趋势之间动态的相互作用，这些因素共同塑造着生医材料产业。变革性的製造方法和协同创新生态系统正在重新定义性能标准，而新关税体系的引入则需要对供应链网路进行积极主动的重组。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：生物材料市场：依类型划分

  • 陶瓷
    • 氧化铝
    • 生物玻璃
    • 羟磷石灰
    • 氧化锆
  • 金属
  • 自然的
  • 合成聚合物
    • PCL（聚己内酯​​）
    • PGA（聚乙醇酸）
    • PLA（聚乳酸）
    • PLGA（聚乳酸-羟基乙酸共聚物）
    • 聚乙烯（PE）
    • 聚丙烯（PP）
    • 聚氨酯（PU）
    • 聚乙烯醇（PVA）

第九章：生物材料市场分类

  • 生物活性物质
  • 生物相容性材料
  • 惰性材料

第十章：生物材料市场：依最终用户划分

  • 生技公司
  • 医院
  • 研究所
  • 专科诊所

第十一章：生物材料市场：依应用领域划分

  • 循环系统
    • 导管导引线
    • 植入式心臟去心房颤动
    • 起搏器
    • 感应器
    • 支架
    • 血管移植
  • 牙科
    • 骨移植材料和骨替代物
    • 人工植牙
    • 牙膜
    • 组织再生材料
  • 眼科
  • 整形外科
    • 生物可吸收组织固定产品
    • 用于关节重建的生物材料
    • 整形外科生物製剂
    • 用于脊椎的生物材料
    • 关节内粘稠补充疗法
  • 泌尿系统
  • 创伤治疗
    • 防沾黏材料
    • 骨折癒合装置
    • 内组织密封胶
    • 皮肤替代材料
    • 外科止血材料

第十二章：生物材料市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章：生物材料市场：依类别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章：生物材料市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国生物材料市场

第十六章：中国生物材料市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Aroa Biosurgery Limited
  • BASF SE
  • Berkeley Advanced Biomaterials Inc.
  • Bezwada Biomedical, LLC
  • Carpenter Technology Corporation
  • Celanese Corporation
  • CoorsTek, Inc.
  • Corbion NV
  • Covestro AG
  • Dentsply Sirona Inc.
  • DSM-Firmenich AG
  • Evonik Industries AG
  • Exactech, Inc.
  • Heraeus Holding GmbH
  • Invibio Limited
  • Medtronic plc
  • Modern Meadow, Inc.
  • MycoWorks, Inc.
  • Noble Biomaterials, Inc.
  • Smith & Nephew plc
  • Stryker Corporation
  • TissueForm, Inc.
Product Code: MRR-434CCDA04CCF

The Biomaterials Market was valued at USD 56.07 billion in 2025 and is projected to grow to USD 63.02 billion in 2026, with a CAGR of 12.92%, reaching USD 131.30 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 56.07 billion
Estimated Year [2026] USD 63.02 billion
Forecast Year [2032] USD 131.30 billion
CAGR (%) 12.92%

Comprehensive Introduction Uncovering the Current Biomaterials Landscape, Core Technology Foundations, and Emerging Research Frontiers Shaping the Industry

Biomaterials have emerged as a pivotal cornerstone in modern healthcare, enabling breakthroughs across tissue engineering, drug delivery, and medical device innovation. In recent years, advances in polymer chemistry, ceramic composites, and metallic alloys have converged to broaden the functional capabilities of implants and regenerative therapies. This introduction provides a foundation for understanding the critical role of biomaterials in enhancing patient outcomes and driving cross-disciplinary collaboration between material scientists, clinicians, and manufacturing specialists.

Emerging research is redefining traditional boundaries, with bioactive ceramics and composite scaffolds integrating biological cues that mimic native tissue microenvironments. Meanwhile, novel metallic frameworks are being engineered to reduce inflammatory responses and improve long-term biocompatibility. In parallel, synthetic polymers are evolving to balance mechanical strength with controlled biodegradation profiles, enabling precision in tissue regeneration protocols.

The interplay between clinical need and material innovation is accelerating the development of personalized solutions, from patient-specific implants to tailored drug delivery platforms. Through understanding both foundational science and applied engineering advances, stakeholders can chart strategic roadmaps that anticipate future demands while mitigating risks inherent in novel product introductions. As we transition into this report, you will gain insights into transformative shifts, trade impacts, segmentation dynamics, and regional nuances shaping the biomaterials landscape.

Revolutionary Transformative Shifts in Biomaterials Development Fueled by Next-Generation Materials, Advanced Manufacturing Techniques, and Collaborative Innovation Models

The biomaterials sector is undergoing a period of rapid transformation driven by next-generation materials and novel manufacturing techniques. Advances in additive manufacturing now enable rapid prototyping of complex implant geometries while ensuring repeatable quality standards. Simultaneously, breakthroughs in nanotechnology are facilitating surface modifications that enhance cellular adhesion and promote accelerated healing responses.

Collaborative innovation models are redefining how academic institutions, start-ups, and established medical device manufacturers co-develop new solutions. By integrating data from real-world evidence platforms and leveraging artificial intelligence algorithms, research teams can optimize material compositions for specific clinical applications more efficiently than ever before. This convergence of digital and materials science is influencing regulatory frameworks, prompting agencies to adopt flexible pathways for validating combination products.

Moreover, sustainability considerations are gaining prominence, prompting industry leaders to explore bio-derived polymers and recyclable composites. The drive toward circular economies is reinforcing investments in biodegradable scaffolds and eco-friendly sourcing practices. Together, these shifts signal a paradigm in which innovation is not only measured by functional performance but also by environmental stewardship and collaborative agility.

Assessing the Cumulative Consequences of New United States Tariffs in 2025 on Supply Chains, Cost Structures, and Competitive Positioning within the Biomaterials Market

The introduction of new United States tariffs in 2025 is poised to reshape the biomaterials supply chain, affecting the cost and availability of critical raw inputs. Ceramics imported from key manufacturing hubs, alongside specialized metallic alloys, may experience increased duty burdens that translate into higher production costs for downstream device manufacturers. In response, companies are evaluating alternative sourcing strategies, including near-shoring and dual-sourcing, to mitigate exposure to trade volatility.

At the same time, synthetic polymers such as PCL and PLA, often produced in regions targeted by the tariffs, could see lead-time fluctuations and margin contractions. This will encourage strategic inventory management and potential consolidation of supplier portfolios. Emerging markets in Europe and Asia Pacific are already positioning themselves as alternative production centers, investing in capacity expansion to capture redirected demand flows.

Despite these challenges, the industry continues to innovate through cost-optimization programs and by exploring tariff classification strategies that align with evolving trade regulations. Companies that proactively engage with customs authorities and diversify their supplier base will be better equipped to absorb short-term shocks and maintain competitive pricing for medical device end users.

Insightful Analysis of Biomaterials Market Segmentation Based on Material Type, Classification, End Users, and Diverse Application Domains Driving Strategic Focus

Analysis of biomaterials market segmentation reveals distinct areas of opportunity tied to material type, functional classification, user groups, and application specialties. Within material type, ceramics such as alumina, bioglass, hydroxyapatite, and zirconia remain pivotal for hard-tissue implants, while metallic substrates continue to underpin load-bearing joint replacements. Natural polymers complement these classes by offering biocompatibility advantages, and synthetic polymers-ranging from polycaprolactone through polylactic-co-glycolic acid to polyvinyl alcohol-provide versatile options for scaffold design and drug delivery matrices.

When considering functional classification, bioactive materials lead in regenerative therapies by actively interacting with biological environments to stimulate tissue growth. Biocompatible materials offer inert scaffolding solutions for long-term implant stability, and bioinert variants provide durable interfaces for devices where tissue response must be minimized. This classification framework guides material selection across diverse biomedical use cases.

End-user segmentation segments the market among biotechnology companies pursuing R&D breakthroughs, hospitals implementing clinical solutions, research laboratories pioneering novel protocols, and specialty clinics delivering targeted therapeutic interventions. Application domains further refine strategic focus areas, with cardiovascular devices-spanning guidewires to vascular grafts-dental innovations from bone graft substitutes to tissue regeneration materials, orthopedic implants including joint replacements and orthobiologics, urinary device technologies, and wound healing systems such as adhesion barriers and surgical hemostats driving specific growth trajectories.

Strategic Regional Insights Unveiling Growth Dynamics and Market Drivers across the Americas, Europe Middle East and Africa, and Asia Pacific Biomaterials Ecosystems

Regional dynamics are central to understanding the biomaterials industry's evolution. In the Americas, robust infrastructure and significant R&D investments create an ecosystem conducive to rapid product development and clinical trials. North American regulatory pathways, characterized by structured approval processes, foster a clear roadmap for innovators, while Latin American markets provide emerging opportunities driven by expanding healthcare access and reform initiatives.

Across Europe, the Middle East, and Africa, diversity in regulatory standards and economic maturity presents both complexity and opportunity. Western Europe's established medical device directives underpin high-value transactions, whereas emerging markets in Eastern Europe and the Gulf region are growing through targeted public-private partnerships and infrastructure enhancements. Africa's nascent healthcare systems are incrementally adopting biomaterial-based interventions, driven by international funding and local capacity building.

The Asia Pacific region stands out for its rapid adoption of advanced healthcare technologies and cost-competitive manufacturing capabilities. Countries in East and Southeast Asia are expanding production hubs for both ceramics and polymers, while regulatory authorities in the region are streamlining approval pathways to attract global investment. Together, these regional ecosystems define the contours of global value chains and strategic market positioning.

Key Company Insights Highlighting Competitive Strategies, Innovation Pipelines, and Collaborative Partnerships Among Leading Biomaterials Providers

Leading companies in the biomaterials sector are differentiating through integrated innovation pipelines and strategic collaborations. Major medical device players, known for extensive global footprints, are augmenting their offerings with proprietary bioactive coatings and advanced polymer formulations. Simultaneously, specialty chemical manufacturers are expanding into clinical markets, leveraging expertise in high-purity materials to meet stringent biocompatibility requirements.

Partnerships between academic institutions and commercial enterprises are accelerating technology transfer, enabling start-ups to scale novel scaffold designs from benchtop validation to regulatory submission. These alliances often involve joint venturing for pilot manufacturing sites and co-development agreements that align intellectual property strategies with market entry timelines. Moreover, several established firms are undertaking targeted acquisitions to fill gaps in regenerative medicine portfolios and reinforce competitive barriers.

Investment trends indicate a growing focus on scalable manufacturing processes, lean supply chains, and digital quality management systems. Companies that optimize their global networks to balance cost efficiency with regulatory compliance will maintain an edge. In parallel, engagement with key opinion leaders and participation in international standards committees reinforce credibility and facilitate market acceptance of next-generation biomaterial solutions.

Actionable Recommendations for Industry Leaders to Capitalize on Emerging Trends, Optimize Supply Chains, and Strengthen Market Position through Strategic Initiatives

Industry leaders should prioritize investment in bioactive and regenerative materials that address unmet clinical needs, leveraging partnerships with research institutions to accelerate translational research. By adopting a modular approach to product development, organizations can validate components individually before integrating them into comprehensive therapy platforms, reducing time to market and mitigating technical risk.

Optimizing supply chains is equally critical. Companies should evaluate dual-sourcing strategies for key raw materials, while exploring near-shoring options to reduce exposure to trade disruptions and shorten lead times. Implementing advanced analytics across procurement and logistics operations will enable real-time visibility, supporting proactive decision-making in response to tariff changes or supplier constraints.

To strengthen market positioning, leadership teams must engage regulatory bodies early in the development lifecycle, seeking alignment on clinical trial design and material characterization requirements. Additionally, pursuing sustainability initiatives-such as recyclable packaging and bio-derived polymer research-will resonate with stakeholder expectations and regulatory trends. Finally, fostering cross-disciplinary talent development programs ensures that internal teams possess the expertise needed to navigate emerging technologies and shifting market dynamics.

Robust Research Methodology Emphasizing Comprehensive Data Collection, Multisource Triangulation, and Rigorous Qualitative and Quantitative Analyses Ensuring Reliability

This analysis leverages a robust research methodology combining comprehensive secondary research with targeted primary interviews and data validation. Publicly available scientific literature, regulatory filings, and patent databases provided foundational insights into material innovations and market developments. These sources were augmented by interviews with material scientists, biomedical engineers, and executive-level decision-makers across supply chain and clinical organizations.

Quantitative data on production volumes, trade flows, and patent filings were triangulated to validate emerging trends, while qualitative feedback from industry stakeholders informed strategic assessments. A rigorous segmentation framework was developed to capture the nuances of material type, functional classification, end-user categories, and application areas.

Throughout the research process, cross-verification mechanisms ensured data integrity, including consistency checks against multiple independent sources and alignment with regional regulatory standards. Competitive benchmarking and scenario analysis were employed to stress-test potential market disruptions, such as tariff impacts and supply chain constraints. This systematic approach underpins the reliability and actionable nature of the insights presented.

Conclusive Insights Synthesizing Key Findings, Highlighting Market Opportunities, and Reinforcing Strategic Priorities for Biomaterials Stakeholders

The findings presented underscore the dynamic interplay of technological innovation, regulatory evolution, and global trade dynamics shaping the biomaterials sector. Transformative manufacturing approaches and collaborative innovation ecosystems are redefining performance benchmarks, while emerging tariff regimes necessitate proactive supply network realignment.

Segmentation insights reveal that targeted investment in bioactive and specialty polymer domains, coupled with strategic engagement of key end-user channels, will unlock high-value opportunities. Regional variations in regulatory complexity and manufacturing capacity highlight the importance of bespoke market entry strategies and localized partnerships.

By integrating these strategic imperatives with agile planning and sustained R&D commitment, companies can position themselves to lead in an environment characterized by rapid scientific advancement and shifting geopolitical landscapes. The path forward requires a balance of innovation, operational resilience, and strategic foresight to drive sustained growth and deliver transformative patient outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Biomaterials Market, by Type

  • 8.1. Ceramics
    • 8.1.1. Alumina
    • 8.1.2. Bioglass
    • 8.1.3. Hydroxyapatite
    • 8.1.4. Zirconia
  • 8.2. Metallic
  • 8.3. Natural
  • 8.4. Synthetic Polymers
    • 8.4.1. PCL (Polycaprolactone)
    • 8.4.2. PGA (Polyglycolic acid)
    • 8.4.3. PLA (Polylactic acid)
    • 8.4.4. PLGA (Polylactic-co-glycolic acid)
    • 8.4.5. Polyethylene (PE)
    • 8.4.6. Polypropylene (PP)
    • 8.4.7. Polyurethane (PU)
    • 8.4.8. Polyvinyl alcohol (PVA)

9. Biomaterials Market, by Classification

  • 9.1. Bioactive Materials
  • 9.2. Biocompatible Materials
  • 9.3. Bioinert Materials

10. Biomaterials Market, by End User

  • 10.1. Biotechnology Companies
  • 10.2. Hospitals
  • 10.3. Research Laboratories
  • 10.4. Specialty Clinics

11. Biomaterials Market, by Application

  • 11.1. Cardiovascular
    • 11.1.1. Guidewires
    • 11.1.2. Implantable Cardiac Defibrillators
    • 11.1.3. Pacemakers
    • 11.1.4. Sensors
    • 11.1.5. Stents
    • 11.1.6. Vascular Grafts
  • 11.2. Dental
    • 11.2.1. Bone Grafts & Substitutes
    • 11.2.2. Dental Implants
    • 11.2.3. Dental Membranes
    • 11.2.4. Tissue Regeneration Materials
  • 11.3. Ophthalmology
  • 11.4. Orthopedic
    • 11.4.1. Bioresorbable Tissue Fixation Products
    • 11.4.2. Joint Replacement biomaterials
    • 11.4.3. Orthobiologics
    • 11.4.4. Spine Biomaterials
    • 11.4.5. Viscosupplementation
  • 11.5. Urinary
  • 11.6. Wound Healing
    • 11.6.1. Adhesion Barrier
    • 11.6.2. Fracture Healing Device
    • 11.6.3. Internal Tissue Sealant
    • 11.6.4. Skin Substitutes
    • 11.6.5. Surgical Hemostats

12. Biomaterials Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Biomaterials Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Biomaterials Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Biomaterials Market

16. China Biomaterials Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Aroa Biosurgery Limited
  • 17.6. BASF SE
  • 17.7. Berkeley Advanced Biomaterials Inc.
  • 17.8. Bezwada Biomedical, LLC
  • 17.9. Carpenter Technology Corporation
  • 17.10. Celanese Corporation
  • 17.11. CoorsTek, Inc.
  • 17.12. Corbion N.V.
  • 17.13. Covestro AG
  • 17.14. Dentsply Sirona Inc.
  • 17.15. DSM-Firmenich AG
  • 17.16. Evonik Industries AG
  • 17.17. Exactech, Inc.
  • 17.18. Heraeus Holding GmbH
  • 17.19. Invibio Limited
  • 17.20. Medtronic plc
  • 17.21. Modern Meadow, Inc.
  • 17.22. MycoWorks, Inc.
  • 17.23. Noble Biomaterials, Inc.
  • 17.24. Smith & Nephew plc
  • 17.25. Stryker Corporation
  • 17.26. TissueForm, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL BIOMATERIALS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BIOMATERIALS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL BIOMATERIALS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL BIOMATERIALS MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BIOMATERIALS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL BIOMATERIALS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BIOMATERIALS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL BIOMATERIALS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BIOMATERIALS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES BIOMATERIALS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA BIOMATERIALS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BIOMATERIALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BIOMATERIALS MARKET SIZE, BY CERAMICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BIOMATERIALS MARKET SIZE, BY CERAMICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BIOMATERIALS MARKET SIZE, BY CERAMICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BIOMATERIALS MARKET SIZE, BY CERAMICS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BIOMATERIALS MARKET SIZE, BY ALUMINA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BIOMATERIALS MARKET SIZE, BY ALUMINA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BIOMATERIALS MARKET SIZE, BY ALUMINA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BIOMATERIALS MARKET SIZE, BY BIOGLASS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BIOMATERIALS MARKET SIZE, BY BIOGLASS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BIOMATERIALS MARKET SIZE, BY BIOGLASS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BIOMATERIALS MARKET SIZE, BY HYDROXYAPATITE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BIOMATERIALS MARKET SIZE, BY HYDROXYAPATITE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BIOMATERIALS MARKET SIZE, BY HYDROXYAPATITE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BIOMATERIALS MARKET SIZE, BY ZIRCONIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BIOMATERIALS MARKET SIZE, BY ZIRCONIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BIOMATERIALS MARKET SIZE, BY ZIRCONIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BIOMATERIALS MARKET SIZE, BY METALLIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL BIOMATERIALS MARKET SIZE, BY METALLIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BIOMATERIALS MARKET SIZE, BY METALLIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BIOMATERIALS MARKET SIZE, BY NATURAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BIOMATERIALS MARKET SIZE, BY NATURAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BIOMATERIALS MARKET SIZE, BY NATURAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BIOMATERIALS MARKET SIZE, BY PCL (POLYCAPROLACTONE), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BIOMATERIALS MARKET SIZE, BY PCL (POLYCAPROLACTONE), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BIOMATERIALS MARKET SIZE, BY PCL (POLYCAPROLACTONE), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BIOMATERIALS MARKET SIZE, BY PGA (POLYGLYCOLIC ACID), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BIOMATERIALS MARKET SIZE, BY PGA (POLYGLYCOLIC ACID), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BIOMATERIALS MARKET SIZE, BY PGA (POLYGLYCOLIC ACID), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BIOMATERIALS MARKET SIZE, BY PLA (POLYLACTIC ACID), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BIOMATERIALS MARKET SIZE, BY PLA (POLYLACTIC ACID), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BIOMATERIALS MARKET SIZE, BY PLA (POLYLACTIC ACID), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL BIOMATERIALS MARKET SIZE, BY PLGA (POLYLACTIC-CO-GLYCOLIC ACID), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL BIOMATERIALS MARKET SIZE, BY PLGA (POLYLACTIC-CO-GLYCOLIC ACID), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL BIOMATERIALS MARKET SIZE, BY PLGA (POLYLACTIC-CO-GLYCOLIC ACID), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL BIOMATERIALS MARKET SIZE, BY POLYETHYLENE (PE), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BIOMATERIALS MARKET SIZE, BY POLYETHYLENE (PE), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BIOMATERIALS MARKET SIZE, BY POLYETHYLENE (PE), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BIOMATERIALS MARKET SIZE, BY POLYPROPYLENE (PP), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BIOMATERIALS MARKET SIZE, BY POLYPROPYLENE (PP), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL BIOMATERIALS MARKET SIZE, BY POLYPROPYLENE (PP), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL BIOMATERIALS MARKET SIZE, BY POLYURETHANE (PU), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BIOMATERIALS MARKET SIZE, BY POLYURETHANE (PU), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BIOMATERIALS MARKET SIZE, BY POLYURETHANE (PU), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BIOMATERIALS MARKET SIZE, BY POLYVINYL ALCOHOL (PVA), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BIOMATERIALS MARKET SIZE, BY POLYVINYL ALCOHOL (PVA), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BIOMATERIALS MARKET SIZE, BY POLYVINYL ALCOHOL (PVA), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL BIOMATERIALS MARKET SIZE, BY BIOACTIVE MATERIALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL BIOMATERIALS MARKET SIZE, BY BIOACTIVE MATERIALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL BIOMATERIALS MARKET SIZE, BY BIOACTIVE MATERIALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL BIOMATERIALS MARKET SIZE, BY BIOCOMPATIBLE MATERIALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL BIOMATERIALS MARKET SIZE, BY BIOCOMPATIBLE MATERIALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL BIOMATERIALS MARKET SIZE, BY BIOCOMPATIBLE MATERIALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL BIOMATERIALS MARKET SIZE, BY BIOINERT MATERIALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL BIOMATERIALS MARKET SIZE, BY BIOINERT MATERIALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL BIOMATERIALS MARKET SIZE, BY BIOINERT MATERIALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL BIOMATERIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL BIOMATERIALS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL BIOMATERIALS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL BIOMATERIALS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL BIOMATERIALS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL BIOMATERIALS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL BIOMATERIALS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL BIOMATERIALS MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL BIOMATERIALS MARKET SIZE, BY RESEARCH LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL BIOMATERIALS MARKET SIZE, BY RESEARCH LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL BIOMATERIALS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL BIOMATERIALS MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL BIOMATERIALS MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL BIOMATERIALS MARKET SIZE, BY GUIDEWIRES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL BIOMATERIALS MARKET SIZE, BY GUIDEWIRES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL BIOMATERIALS MARKET SIZE, BY GUIDEWIRES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL BIOMATERIALS MARKET SIZE, BY IMPLANTABLE CARDIAC DEFIBRILLATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL BIOMATERIALS MARKET SIZE, BY IMPLANTABLE CARDIAC DEFIBRILLATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL BIOMATERIALS MARKET SIZE, BY IMPLANTABLE CARDIAC DEFIBRILLATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL BIOMATERIALS MARKET SIZE, BY PACEMAKERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL BIOMATERIALS MARKET SIZE, BY PACEMAKERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL BIOMATERIALS MARKET SIZE, BY PACEMAKERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL BIOMATERIALS MARKET SIZE, BY SENSORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL BIOMATERIALS MARKET SIZE, BY SENSORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL BIOMATERIALS MARKET SIZE, BY SENSORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL BIOMATERIALS MARKET SIZE, BY STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL BIOMATERIALS MARKET SIZE, BY STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL BIOMATERIALS MARKET SIZE, BY STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL BIOMATERIALS MARKET SIZE, BY VASCULAR GRAFTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL BIOMATERIALS MARKET SIZE, BY VASCULAR GRAFTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL BIOMATERIALS MARKET SIZE, BY VASCULAR GRAFTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL BIOMATERIALS MARKET SIZE, BY DENTAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL BIOMATERIALS MARKET SIZE, BY DENTAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL BIOMATERIALS MARKET SIZE, BY DENTAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL BIOMATERIALS MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL BIOMATERIALS MARKET SIZE, BY BONE GRAFTS & SUBSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL BIOMATERIALS MARKET SIZE, BY BONE GRAFTS & SUBSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL BIOMATERIALS MARKET SIZE, BY BONE GRAFTS & SUBSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL BIOMATERIALS MARKET SIZE, BY DENTAL IMPLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL BIOMATERIALS MARKET SIZE, BY DENTAL IMPLANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL BIOMATERIALS MARKET SIZE, BY DENTAL IMPLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL BIOMATERIALS MARKET SIZE, BY DENTAL MEMBRANES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL BIOMATERIALS MARKET SIZE, BY DENTAL MEMBRANES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL BIOMATERIALS MARKET SIZE, BY DENTAL MEMBRANES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL BIOMATERIALS MARKET SIZE, BY TISSUE REGENERATION MATERIALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL BIOMATERIALS MARKET SIZE, BY TISSUE REGENERATION MATERIALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL BIOMATERIALS MARKET SIZE, BY TISSUE REGENERATION MATERIALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL BIOMATERIALS MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL BIOMATERIALS MARKET SIZE, BY OPHTHALMOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL BIOMATERIALS MARKET SIZE, BY OPHTHALMOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL BIOMATERIALS MARKET SIZE, BY BIORESORBABLE TISSUE FIXATION PRODUCTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL BIOMATERIALS MARKET SIZE, BY BIORESORBABLE TISSUE FIXATION PRODUCTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL BIOMATERIALS MARKET SIZE, BY BIORESORBABLE TISSUE FIXATION PRODUCTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL BIOMATERIALS MARKET SIZE, BY JOINT REPLACEMENT BIOMATERIALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL BIOMATERIALS MARKET SIZE, BY JOINT REPLACEMENT BIOMATERIALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL BIOMATERIALS MARKET SIZE, BY JOINT REPLACEMENT BIOMATERIALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL BIOMATERIALS MARKET SIZE, BY ORTHOBIOLOGICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL BIOMATERIALS MARKET SIZE, BY ORTHOBIOLOGICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL BIOMATERIALS MARKET SIZE, BY ORTHOBIOLOGICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL BIOMATERIALS MARKET SIZE, BY SPINE BIOMATERIALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL BIOMATERIALS MARKET SIZE, BY SPINE BIOMATERIALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL BIOMATERIALS MARKET SIZE, BY SPINE BIOMATERIALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL BIOMATERIALS MARKET SIZE, BY VISCOSUPPLEMENTATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL BIOMATERIALS MARKET SIZE, BY VISCOSUPPLEMENTATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL BIOMATERIALS MARKET SIZE, BY VISCOSUPPLEMENTATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL BIOMATERIALS MARKET SIZE, BY URINARY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL BIOMATERIALS MARKET SIZE, BY URINARY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL BIOMATERIALS MARKET SIZE, BY URINARY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL BIOMATERIALS MARKET SIZE, BY WOUND HEALING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL BIOMATERIALS MARKET SIZE, BY WOUND HEALING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL BIOMATERIALS MARKET SIZE, BY WOUND HEALING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL BIOMATERIALS MARKET SIZE, BY ADHESION BARRIER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL BIOMATERIALS MARKET SIZE, BY ADHESION BARRIER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL BIOMATERIALS MARKET SIZE, BY ADHESION BARRIER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL BIOMATERIALS MARKET SIZE, BY FRACTURE HEALING DEVICE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL BIOMATERIALS MARKET SIZE, BY FRACTURE HEALING DEVICE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL BIOMATERIALS MARKET SIZE, BY FRACTURE HEALING DEVICE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL BIOMATERIALS MARKET SIZE, BY INTERNAL TISSUE SEALANT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL BIOMATERIALS MARKET SIZE, BY INTERNAL TISSUE SEALANT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL BIOMATERIALS MARKET SIZE, BY INTERNAL TISSUE SEALANT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL BIOMATERIALS MARKET SIZE, BY SKIN SUBSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL BIOMATERIALS MARKET SIZE, BY SKIN SUBSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL BIOMATERIALS MARKET SIZE, BY SKIN SUBSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL BIOMATERIALS MARKET SIZE, BY SURGICAL HEMOSTATS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL BIOMATERIALS MARKET SIZE, BY SURGICAL HEMOSTATS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL BIOMATERIALS MARKET SIZE, BY SURGICAL HEMOSTATS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL BIOMATERIALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 160. AMERICAS BIOMATERIALS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 161. AMERICAS BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. AMERICAS BIOMATERIALS MARKET SIZE, BY CERAMICS, 2018-2032 (USD MILLION)
  • TABLE 163. AMERICAS BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 164. AMERICAS BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2032 (USD MILLION)
  • TABLE 165. AMERICAS BIOMATERIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 166. AMERICAS BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 167. AMERICAS BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 168. AMERICAS BIOMATERIALS MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 169. AMERICAS BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 170. AMERICAS BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2018-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA BIOMATERIALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. NORTH AMERICA BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA BIOMATERIALS MARKET SIZE, BY CERAMICS, 2018-2032 (USD MILLION)
  • TABLE 174. NORTH AMERICA BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2032 (USD MILLION)
  • TABLE 176. NORTH AMERICA BIOMATERIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 178. NORTH AMERICA BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 179. NORTH AMERICA BIOMATERIALS MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 180. NORTH AMERICA BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 181. NORTH AMERICA BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2018-2032 (USD MILLION)
  • TABLE 182. LATIN AMERICA BIOMATERIALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 183. LATIN AMERICA BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. LATIN AMERICA BIOMATERIALS MARKET SIZE, BY CERAMICS, 2018-2032 (USD MILLION)
  • TABLE 185. LATIN AMERICA BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 186. LATIN AMERICA BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2032 (USD MILLION)
  • TABLE 187. LATIN AMERICA BIOMATERIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. LATIN AMERICA BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 189. LATIN AMERICA BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 190. LATIN AMERICA BIOMATERIALS MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 192. LATIN AMERICA BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE, MIDDLE EAST & AFRICA BIOMATERIALS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE, MIDDLE EAST & AFRICA BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA BIOMATERIALS MARKET SIZE, BY CERAMICS, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA BIOMATERIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA BIOMATERIALS MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPE BIOMATERIALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPE BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPE BIOMATERIALS MARKET SIZE, BY CERAMICS, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPE BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPE BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPE BIOMATERIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPE BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPE BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPE BIOMATERIALS MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPE BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPE BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2018-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST BIOMATERIALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 216. MIDDLE EAST BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 217. MIDDLE EAST BIOMATERIALS MARKET SIZE, BY CERAMICS, 2018-2032 (USD MILLION)
  • TABLE 218. MIDDLE EAST BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 219. MIDDLE EAST BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2032 (USD MILLION)
  • TABLE 220. MIDDLE EAST BIOMATERIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 221. MIDDLE EAST BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 222. MIDDLE EAST BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 223. MIDDLE EAST BIOMATERIALS MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 224. MIDDLE EAST BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 225. MIDDLE EAST BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2018-2032 (USD MILLION)
  • TABLE 226. AFRICA BIOMATERIALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 227. AFRICA BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 228. AFRICA BIOMATERIALS MARKET SIZE, BY CERAMICS, 2018-2032 (USD MILLION)
  • TABLE 229. AFRICA BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 230. AFRICA BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2032 (USD MILLION)
  • TABLE 231. AFRICA BIOMATERIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 232. AFRICA BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 233. AFRICA BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 234. AFRICA BIOMATERIALS MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 235. AFRICA BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 236. AFRICA BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2018-2032 (USD MILLION)
  • TABLE 237. ASIA-PACIFIC BIOMATERIALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 238. ASIA-PACIFIC BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 239. ASIA-PACIFIC BIOMATERIALS MARKET SIZE, BY CERAMICS, 2018-2032 (USD MILLION)
  • TABLE 240. ASIA-PACIFIC BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 241. ASIA-PACIFIC BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2032 (USD MILLION)
  • TABLE 242. ASIA-PACIFIC BIOMATERIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 243. ASIA-PACIFIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 244. ASIA-PACIFIC BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 245. ASIA-PACIFIC BIOMATERIALS MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 246. ASIA-PACIFIC BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 247. ASIA-PACIFIC BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2018-2032 (USD MILLION)
  • TABLE 248. GLOBAL BIOMATERIALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 249. ASEAN BIOMATERIALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 250. ASEAN BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 251. ASEAN BIOMATERIALS MARKET SIZE, BY CERAMICS, 2018-2032 (USD MILLION)
  • TABLE 252. ASEAN BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 253. ASEAN BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2032 (USD MILLION)
  • TABLE 254. ASEAN BIOMATERIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 255. ASEAN BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 256. ASEAN BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 257. ASEAN BIOMATERIALS MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 258. ASEAN BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 259. ASEAN BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2018-2032 (USD MILLION)
  • TABLE 260. GCC BIOMATERIALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 261. GCC BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 262. GCC BIOMATERIALS MARKET SIZE, BY CERAMICS, 2018-2032 (USD MILLION)
  • TABLE 263. GCC BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 264. GCC BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2032 (USD MILLION)
  • TABLE 265. GCC BIOMATERIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 266. GCC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 267. GCC BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 268. GCC BIOMATERIALS MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 269. GCC BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 270. GCC BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2018-2032 (USD MILLION)
  • TABLE 271. EUROPEAN UNION BIOMATERIALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 272. EUROPEAN UNION BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 273. EUROPEAN UNION BIOMATERIALS MARKET SIZE, BY CERAMICS, 2018-2032 (USD MILLION)
  • TABLE 274. EUROPEAN UNION BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 275. EUROPEAN UNION BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2032 (USD MILLION)
  • TABLE 276. EUROPEAN UNION BIOMATERIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 277. EUROPEAN UNION BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 278. EUROPEAN UNION BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 279. EUROPEAN UNION BIOMATERIALS MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 280. EUROPEAN UNION BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 281. EUROPEAN UNION BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2018-2032 (USD MILLION)
  • TABLE 282. BRICS BIOMATERIALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 283. BRICS BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 284. BRICS BIOMATERIALS MARKET SIZE, BY CERAMICS, 2018-2032 (USD MILLION)
  • TABLE 285. BRICS BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 286. BRICS BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2032 (USD MILLION)
  • TABLE 287. BRICS BIOMATERIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 288. BRICS BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 289. BRICS BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 290. BRICS BIOMATERIALS MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 291. BRICS BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 292. BRICS BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2018-2032 (USD MILLION)
  • TABLE 293. G7 BIOMATERIALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 294. G7 BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 295. G7 BIOMATERIALS MARKET SIZE, BY CERAMICS, 2018-2032 (USD MILLION)
  • TABLE 296. G7 BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 297. G7 BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2032 (USD MILLION)
  • TABLE 298. G7 BIOMATERIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 299. G7 BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 300. G7 BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 301. G7 BIOMATERIALS MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 302. G7 BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 303. G7 BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2018-2032 (USD MILLION)
  • TABLE 304. NATO BIOMATERIALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 305. NATO BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 306. NATO BIOMATERIALS MARKET SIZE, BY CERAMICS, 2018-2032 (USD MILLION)
  • TABLE 307. NATO BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 308. NATO BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2032 (USD MILLION)
  • TABLE 309. NATO BIOMATERIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 310. NATO BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 311. NATO BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 312. NATO BIOMATERIALS MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 313. NATO BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 314. NATO BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2018-2032 (USD MILLION)
  • TABLE 315. GLOBAL BIOMATERIALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 316. UNITED STATES BIOMATERIALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 317. UNITED STATES BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 318. UNITED STATES BIOMATERIALS MARKET SIZE, BY CERAMICS, 2018-2032 (USD MILLION)
  • TABLE 319. UNITED STATES BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 320. UNITED STATES BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2032 (USD MILLION)
  • TABLE 321. UNITED STATES BIOMATERIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 322. UNITED STATES BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 323. UNITED STATES BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 324. UNITED STATES BIOMATERIALS MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 325. UNITED STATES BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 326. UNITED STATES BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2018-2032 (USD MILLION)
  • TABLE 327. CHINA BIOMATERIALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 328. CHINA BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 329. CHINA BIOMATERIALS MARKET SIZE, BY CERAMICS, 2018-2032 (USD MILLION)
  • TABLE 330. CHINA BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 331. CHINA BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2032 (USD MILLION)
  • TABLE 332. CHINA BIOMATERIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 333. CHINA BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 334. CHINA BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 335. CHINA BIOMATERIALS MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 336. CHINA BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 337. CHINA BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2018-2032 (USD MILLION)